lung cancer
Conditions
Interventions
Sponsors
Shanghai Chest Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The first stage: (1) Aged 18-75 years old; (2) in patients with nodules found in the lungs by low-dose or ordinary CT examination, the nodules are 5 mm-3 cm in size, and there is only one nodule per patient in this range, and other nodules less than or equal to 5 mm are allowed to exist at the same time; (3) the nodules were confirmed as benign or malignant by tracheoscopy, puncture biopsy or operation and pathology; (4) the CT of the patient must be a high-resolution three-bit reconstruction image of Shanghai Thoracic Hospital. The second stage: Part one: (1) over 18 years of age; (2) in patients with nodules found in the lungs by low-dose or ordinary CT examination, the nodules are 5 mm-3 cm in size, and there is only one nodule per patient in this range, and other nodules less than or equal to 5 mm are allowed to exist at the same time; (3) the CT of the patient must be a high-resolution three-bit reconstruction image of Shanghai Thoracic Hospital. The second part: (1) Aged 18-75 years old; (2) patients with non-small cell lung cancer confirmed by pathology. The third part: (1) Aged 18-75 years old; (2) patients with advanced non-small cell lung cancer confirmed by pathology.
Exclusion criteria
Exclusion criteria: The first stage: (1) patients with a history of stroke, pneumonia, COPD and pulmonary hypertension. (2) patients with hypertension and hyperglycemia are not well controlled. (3) patients with suspected multicentric ground glass nodules. (4) patients who can not cooperate with skin fluorescence detection. The second stage: Part one: (1) patients with a history of stroke, pneumonia, COPD and pulmonary hypertension. (2) patients with hypertension and hyperglycemia are not well controlled. (3) patients with suspected multicentric ground glass nodules. (4) patients who can not cooperate with skin fluorescence detection. The second part: (1) patients with a history of stroke, pneumonia, COPD and pulmonary hypertension. (2) patients with hypertension and hyperglycemia are not well controlled. (3) patients who can not cooperate with skin fluorescence detection. The third part: (1) patients with a history of stroke, pneumonia, COPD and pulmonary hypertension. (2) patients with hypertension and hyperglycemia are not well controlled. (3) patients who can not cooperate with skin fluorescence detection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin green autofluorescence;SEN, SPE, ACC, AUC of ROC; | — |
Countries
China
Contacts
Public ContactTianqing Chu
Shanghai Chest Hospital
Outcome results
None listed